LONDON/NEW YORK, June 9 (Reuters) - U.S. healthcare IT company Allscripts plans to buy rival Eclipsys in a $1.3 billion all-stock deal to capitalize on a huge influx of U.S. government funding for ...

Allscripts and Eclipsys agreed to merge in a $1.3 billion deal today: Allscripts CEO Glen Tullman will become CEO of the combined company, while Phil Pead, president and CEO of Eclipsys will become ...